Bioequivalence Studies With Pharmacokinetic Endpoints for Drugs Submitted Under an Abbreviated New Drug Application; Guidance for Industry
NonrulemakingOtherFDA-2013-D-1464-0023
Document
Details
The document's own metadata, straight from regulations.gov.
- Posted
- May 29, 2026
- Agency
- Food and Drug Administration (FDA)